LMCYX
Price
$34.37
Change
+$0.66 (+1.96%)
Updated
Feb 3 closing price
Net Assets
1.14B
MVCAX
Price
$31.51
Change
-$0.46 (-1.44%)
Updated
Feb 3 closing price
Net Assets
17.11B
Interact to see
Advertisement

LMCYX vs MVCAX

Header iconLMCYX vs MVCAX Comparison
Open Charts LMCYX vs MVCAXBanner chart's image
Lord Abbett Mid Cap Stock I
Price$34.37
Change+$0.66 (+1.96%)
VolumeN/A
Net Assets1.14B
MFS Mid Cap Value A
Price$31.51
Change-$0.46 (-1.44%)
VolumeN/A
Net Assets17.11B
LMCYX vs MVCAX Comparison Chart in %
View a ticker or compare two or three
VS
LMCYX vs. MVCAX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMCYX is a Buy and MVCAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.1B vs. LMCYX (1.15B). MVCAX pays higher dividends than LMCYX: MVCAX (1.20) vs LMCYX (0.66). LMCYX was incepted earlier than MVCAX: LMCYX (27 years) vs MVCAX (24 years). MVCAX (1.00) is less costly to investors than LMCYX (0.77). LMCYX is a more actively managed with annual turnover of: 53.00 vs. MVCAX (24.00). MVCAX has a lower initial minimum investment than LMCYX: MVCAX (1000) vs LMCYX (1000000). MVCAX annual gain was more profitable for investors over the last year : 1.90 vs. LMCYX (0.67). MVCAX return over 5 years is better than : 23.95 vs. LMCYX (20.15).
LMCYXMVCAXLMCYX / MVCAX
Total Expense Ratio0.770.9978%
Annual Report Gross Expense Ratio0.771.0077%
Fund Existence27 years24 years-
Gain YTD3.2444.78968%
Front LoadN/A6%-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.15B17.1B7%
Annual Yield % from dividends0.661.2055%
Returns for 1 year0.671.9035%
Returns for 3 years16.8011.13151%
Returns for 5 years20.1523.9584%
Returns for 10 years66.2499.0967%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RKLB81.277.12
+9.60%
Rocket Lab Corporation
SRZN23.080.98
+4.43%
Surrozen
HASI35.250.81
+2.35%
HA Sustainable Infrastructure Capital Inc.
BBOT11.88-0.15
-1.25%
BridgeBio Oncology Therapeutics Inc
NVNI1.62-0.03
-1.82%
Nvni Group Limited